PATHOLOGY TECHNOLOGY Australia Member Update
Pathology Technology Australia warmly invites you to join us for breakfast at the 2019 RCPA Pathology Update.
Details - Save the Date
Date: Friday February 22, 2019
Venue: Melbourne Convention Centre, Melbourne, Australia
Time: 7:30am - 9:00am
This year’s February Update Networking Event is focused on: Developing and Expanding our Market Access; and Influencing Political Agendas
Friday 22 February 2019
7:30AM - 9:00AM
Melbourne Convention and Exhibition Centre
‘New Technologies and the MSAC Process: A User’s Perspective’
Pathology Technology Australia’s pilot project HbA1c MSAC submission is near completion. We have commenced two new submissions, with a third under consideration. Rita will share her experiences of preparing MSAC submissions, highlighting some unique point-of-care aspects and speak to some of the changes that may be needed to ensure the responsiveness of the MBS to patient needs.
Rita Karamy BPharm, Grad Dip Health Econ and Policy
Rita is an Engagement Manager at Health Technology Analysts where she works alongside a high-calibre team.
Day-to-day, Rita works with clients in the preparation of reimbursement submissions to the Australian Department of Health and to the New Zealand Ministry of Health for consideration of funding for pharmaceuticals and medical devices. Her role encompasses a range of health technology assessment aspects including appraisals of clinical evidence, developing economic models, estimation of market uptake and financial impacts. Rita also provides consultation to the Department of Health in the form of evaluating and assessing proposals for the listing of medical services such as diagnostics, devices and surgical procedures, onto the Medicare Benefits Scheme (MBS).
Influencing the Political Agenda by Increasing the Awareness of Pathology
Being relevant ensures sustainability. Being a cost centre leads to cost reduction. Adding value ensure people care. We all know that 70% of medical decisions rely on pathology and that 100% of cancer is diagnosed by pathology; but getting politicians and consumers to appreciate the VALUE of pathology is a journey and a hard road that must be travelled. John will look at the impact of our Know Pathology Know Healthcare (KPKH) Campaign on the recognition of the value of pathology in Australia. He will also share the strategy for the coming 12-18 months and expected outcomes.
John Crothers BSc(MLS), Grad Dip Bus Admin, GAICD.
Chair of Pathology Awareness Australia and the Regional Director at Abbott Diagnostics.
John Crothers is the Regional Director for Australia and New Zealand. Prior to the role in Australia, John was the Commercial Director for Asia Pacific and has also had several years in US Marketing. With over 25 years’ experience in the pathology industry in both the laboratory and IVD, the appreciation of the value of the industry in healthcare is a passion that John continues to pursue. John has a BSc(MLS) from RMIT, a Graduate Diploma in Business Administration from Swinburne University & a Graduate of the Australian Institute of Company Directors.